Related Experiment Videos
A transgenic mouse model for trilateral retinoblastoma.
J M O'Brien1, D M Marcus, R Bernards
1Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston 02114.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|August 1, 1990
Summary
Researchers developed a mouse model for trilateral retinoblastoma, a rare cancer involving the eye and brain. This model mimics human retinoblastoma, offering insights into tumor development and potential therapeutic targets.
Area of Science:
- Oncology
- Genetics
- Ophthalmology
Background:
- Trilateral retinoblastoma is a rare, aggressive cancer involving ocular and central nervous system tumors.
- The retinoblastoma gene product (p105-Rb) plays a crucial role in cell cycle regulation and tumor suppression.
- Understanding retinoblastoma tumorigenesis is critical for developing effective treatments.
Purpose of the Study:
- To establish and characterize a novel murine model for trilateral retinoblastoma.
- To investigate the genetic and molecular mechanisms underlying retinoblastoma and associated CNS tumors.
- To provide a platform for preclinical studies of retinoblastoma.
Main Methods:
- Transgenic mice expressing SV40 T-antigen in retinal cells were generated.
- Tumor development, characteristics, and heritability were assessed.
- Histopathological, electron microscopic, and immunohistochemical analyses were performed.
Main Results:
- All transgenic mice developed multifocal retinal tumors resembling human retinoblastoma.
- Approximately 15% of mice also developed midbrain tumors, correlating with human trilateral retinoblastoma.
- Ocular and CNS neoplasms were heritable across 10 generations.
- Tumors exhibited features consistent with human retinoblastoma and CNS neoplasms.
Conclusions:
- The developed murine model accurately recapitulates key features of human trilateral retinoblastoma.
- This model provides a valuable tool for studying retinoblastoma tumorigenesis and evaluating therapeutic strategies.
- Findings suggest a potential mechanism involving local functional inactivation of retinoblastoma protein.